skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

About Karolina

UK

+1 year(s) experience

Karolina Kujawa
As an analyst, Karolina Kujawa covers infectious diseases as well as select immunology & inflammation and metabolic indications for Datamonitor Healthcare and Biomedtracker. To provide insightful analysis, Karolina draws from her background in Biomedical Sciences and Pharmaceutical Economics to understand the science behind drugs while accounting for market dynamics.

Through her projects, Karolina gained expertise on a wide variety of markets, ranging from blockbuster drugs, such as pneumococcal vaccines, to neglected tropical diseases like dengue fever.

She specializes in infectious disease vaccines, including vaccines for pneumococcal and meningococcal diseases, respiratory syncytial virus (RSV), and dengue fever. She also covers certain immunology & inflammation diseases, such as systemic lupus erythematosus (SLE), as well as select metabolic indications.

Before joining Informa in 2017, Karolina completed a degree in Biomedical Sciences, focused on infectious diseases and cell biology, at Univeristy College London and a Masters in Pharmaceutical Economics at the London School of Economics.

Analyst Articles

Articles by Karolina

  • Datamonitor Healthcare

    Meningococcal Vaccines Forecast Infographic

    By Karolina Kujawa 28 Aug 2018

    Over 1.2 million cases of bacterial meningitis are estimated to occur worldwide each year. If not treated promptly, up to half of those cases will be fatal. This infographic from Datamonitor Healthcare provides a snapshot of the meningococcal vaccines market in the US and five major EU markets. What does the meningococcal vaccines market have in store and how will it affect your business? Download now.

    Topic Vaccines